New Research Shifts Understanding of Lacunar Ischemic Stroke
July 5, 11:00 PM
A groundbreaking study published in the journal Circulation has found that lacunar ischemic stroke is caused by pathological dilation of the brain's microvessels, rather than fatty plaque buildup. By analyzing data from 229 patients who had suffered either a lacunar or mild non-lacunar stroke, researchers discovered that individuals with enlarged microvessels face more than a fourfold higher risk of developing lacunar stroke. This finding could significantly reshape prevention and treatment strategies for this common stroke subtype.
Study Design and Key Findings
Participants underwent magnetic resonance imaging (MRI) scans immediately after their stroke and again one year later. The results revealed that one in four patients experienced silent strokes despite receiving standard preventive therapy. These insights have laid the groundwork for the LACI-3 clinical trial, which is currently evaluating the effectiveness of cilostazol and isosorbide mononitrate. The project is funded by UK medical foundations and involves researchers from China and Mexico.
'Understanding the microvascular nature of lacunar stroke is the key to developing effective drugs,' said Joanna Wardlaw.
This discovery could pave the way for novel approaches in treating and preventing lacunar ischemic stroke, marking a significant step forward in medical science.
The research underscores the importance of uncovering the mechanisms behind lacunar stroke, as traditional preventive methods may prove inadequate. Identifying new biomarkers and disease pathways may transform patient care, particularly through the development of targeted medications. Future results from the LACI-3 clinical trial have the potential to reshape standard stroke treatment and prevention protocols worldwide.